Applying public health principles to the HIV epidemic-how are we doing?

New England Journal of Medicine

Volumn 373, Issue 23, 2015, Pages 2281-2287

  Frieden, Thomas R ^a   Foti, Kathryn E ^a   Mermin, Jonathan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANAL INTERCOURSE; ARTICLE; BISEXUALITY; CONTROLLED STUDY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ENVIRONMENTAL EXPOSURE; EPIDEMIC; ETHNICITY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HOMOSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PUBLIC HEALTH; RACE DIFFERENCE; SEX DIFFERENCE; SEXUAL TRANSMISSION; VIRUS LOAD; YOUNG ADULT; EPIDEMICS; HEALTH SURVEY; HIGH RISK BEHAVIOR; HIV INFECTIONS; PUBLIC HEALTH SERVICE; UNITED STATES; UNSAFE SEX;

ADOLESCENT; ADULT; EPIDEMICS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PUBLIC HEALTH PRACTICE; RISK-TAKING; UNITED STATES; UNSAFE SEX; YOUNG ADULT;

EID: 84948783431     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMms1513641     Document Type: Article

References (45)

1. Frieden TR, Das-Douglas M, Kellerman SE, Henning KJ. Applying public health principles to the HIV epidemic. N Engl J Med 2005; 353: 2397-402.
2. Epidemiology of HIV/AIDS-United States, 1981-2005. MMWR Morb Mortal Wkly Rep 2006; 55: 589-92.
3. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 dependent areas-2013. Atlanta: Centers for Disease Control and Prevention, 2015 (http://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillancereport-vol20-no2.pdf).
4. Johnson AS, Hall HI, Hu X, Lansky A, Holtgrave DR, Mermin J. Trends in diagnoses of HIV infection in the United States, 2002-2011. JAMA 2014; 312: 432-4.
5. HIV surveillance report, 2014. Atlanta: Centers for Disease Control and Prevention, 2015 (http://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-us.pdf).
6. Harrison KM, Song R, Zhang X. Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr 2010; 53: 124-30.
7. Laboratory testing for the diagnosis of HIV infection: updated recommendations. Atlanta: Centers for Disease Control and Prevention and Association of Public Health Laboratories, 2014 (http://www.cdc.gov/hiv/pdf/hivtestingalgorithmrecommendation-final.pdf.).
8. Panel on Antiretroviral Guidelines for Adults. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Washington, DC: Department of Health and Human Services, April 2015 (http://www.aidsinfo .nih.gov/ContentFiles/AdultandAdolescentGL.pdf).
9. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
10. Danel C, Moh R, Gabillard D, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med 2015; 373: 808-22.
11. Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015; 373: 795-807.
12. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363: 2587-99.
13. HIV testing and risk behaviors among gay, bisexual, and other men who have sex with men-United States. MMWR Morb Mortal Wkly Rep 2013; 62: 958-62.
14. HIV infection and HIV-associated behaviors among persons who inject drugs-20 cities, United States, 2012. MMWR Morb Mortal Wkly Rep 2015; 64: 270-5.
15. Community outbreak of HIV infection linked to injection drug use of oxymorphone-Indiana, 2015. MMWR Morb Mortal Wkly Rep 2015; 64: 443-4.
16. Prevalence of undiagnosed HIV infection among persons aged ≥13 years-National HIV Surveillance System, United States, 2005-2008. MMWR Morb Mortal Wkly Rep 2012; 61: Suppl: 57-64.
17. Cases of HIV infection and AIDS in the United States, 2003. Atlanta: Centers for Disease Control and Prevention, 2004 (http://www.cdc.gov/hiv/pdf/statistics-2003-HIV-Surveillance-Report-vol-15.pdf).
18. HIV surveillance-men who have sex with men (MSM) (through 2013). Atlanta: Centers for Disease Control and Prevention, 2015 (http://www.cdc.gov/HIV/library/slidesets/index.html).
19. Baggaley RF, Dimitrov D, Owen BN, et al. Heterosexual anal intercourse: a neglected risk factor for HIV? Am J Reprod Immunol 2013; 69: Suppl 1: 95-105.
20. McBride KR, Fortenberry JD. Heterosexual anal sexuality and anal sex behaviors: a review. J Sex Res 2010; 47: 123-36.
21. Niccolai LM, Farley TA, Ayoub MA, Magnus M, Kissinger PJ. HIV-infected persons' knowledge of their sexual partners' HIV status. AIDS Educ Prev 2002; 14: 183-9.
22. Cohen MS, Shaw GM, McMichael AJ, Haynes BF. Acute HIV-1 infection. N Engl J Med 2011; 364: 1943-54.
23. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55(RR-14): 1-17.
24. Human immunodeficiency virus (HIV) infection: screening, April 2013. Washington, DC: Preventive Services Task Force, 2013 (http://www.uspreventiveservicestaskforce .org/Page/Document/RecommendationStatementFinal/human-immunodeficiency-virus-hiv-infection-screening).
25. Hall HI, Tang T, Espinoza L. Late HIV diagnosis in metropolitan areas of the United States and Puerto Rico. Presented at the Conference on Retroviruses and Opportunistic Infections, Seattle, February 23-26, 2015.
26. Malave MC, Shah D, Sackoff JE, Rubin S, Begier EM. Human immunodeficiency virus partner elicitation and notification in New York City: public health does it better. Sex Transm Dis 2008; 35: 869-76.
27. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep 2008; 57(RR-9): 1-83.
28. Munsiff SS, Ahuja SD, King L, et al. Ensuring accountability: the contribution of the cohort review method to tuberculosis control in New York City. Int J Tuberc Lung Dis 2006; 10: 1133-9.
29. Xia Q, Kersanske LS, Wiewel EW, Braunstein SL, Shepard CW, Torian LV. Proportions of patients with HIV retained in care and virally suppressed in New York City and the United States: higher than we thought. J Acquir Immune Defic Syndr 2015; 68: 351-8.
30. Skarbinski J, Rosenberg E, Paz-Bailey G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med 2015; 175: 588-96.
31. Landovitz RJ. Preexposure prophylaxis for HIV prevention: what we know and what we still need to know for implementation. Top Antivir Med 2015; 23: 85-90.
32. McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2015 September 9 (Epub ahead of print).
33. Montaner JS, Lima VD, Harrigan PR, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting. PLoS One 2014; 9(2): e87872.
34. Zetola NM, Grijalva CG, Gertler S, et al. Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007. PLoS One 2008; 3(7): e2591.
35. Truong HM, Kellogg T, Louie B, Klausner J, Dilley J, McFarland W. Recent HIV-1 infection detection: comparison of incidence estimates derived by laboratory assays and repeat testing data. J Acquir Immune Defic Syndr 2009; 51: 502-5.
36. Zetola NM, Mintie A, Liska S, et al. Performance of a transcription-mediated-amplification HIV-1 RNA assay in pooled specimens. J Clin Virol 2007; 40: 68-70.
37. Marcus JL, Bernstein KT, Klausner JD. Updated outcomes of partner notification for human immunodeficiency virus, San Francisco, 2004-2008. AIDS 2009; 23: 1024-6.
38. Buchacz K, Chen MJ, Parisi MK, et al. Using HIV surveillance registry data to re-link persons to care: the RSVP Project in San Francisco. PLoS One 2015; 10(3): e0118923.
39. HIV epidemiology annual report 2014. San Francisco: San Francisco Department of Public Health, 2014 (https://www.sfdph .org/dph/files/reports/RptsHIVAIDS/HIV-EpidemiologyAnnual Report-2014.pdf).
40. Daskalaskis DC. The ending the epidemic task force: New York City Health Department New York: New York City Department of Health and Mental Hygiene (https://www.health .ny.gov/diseases/aids/ending-the-epidemic/meetings/docs/ete-nycdohmh.pdf).
41. Udeagu CCN, Webster TR, Bocour A, Michel P, Shepard CW. Lost or just not following up: public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care. AIDS 2013; 27: 2271-9.
42. Wiewel EW, Torian LV, Xia Q, Braunstein SL. Linkage to care and viral suppression among new HIV diagnoses, New York City, 2006-13. Presented at the Conference on Retroviruses and Opportunistic Infections, Seattle, February 23-26, 2015 (http://www.croiconference .org/sessions/linkage-care-and-viral-suppression-among-new-hiv-diagnoses-new-york-city-2006-13).
43. National HIV/AIDS Strategy for the United States: updated to 2020. Washington, DC: White House Office of National AIDS Policy, 2015 (https://www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-update.pdf).
44. Executive order-HIV care continuum initiative. Washington, DC: The White House, 2013 (https://www.whitehouse.gov/the-press-office/2013/07/15/executive-order-hiv-care-continuum-initiative).
45. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS, 2014 (http://www.unaids .org/sites/default/files/media-asset/90-90-90-en-0.pdf).